Schedule 13D ownership disclosure
Innate Pharma SA
Security class unavailable · CUSIP: 45781K105
Event date: 2022-11-23
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 6,389,406
- Percent of class
- 8.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-22-124799
- Form type
- SC 13D
- Filer
- Bpifrance Participations SA
- CIK
- CIK 1581835
- Filed
- Dec 06, 2022
- Reporting period
- Nov 23, 2022
- Description
- Schedule 13D beneficial ownership